These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9879680)

  • 1. Cytokine and chemokine mRNA expressing cells in muscle tissues of experimental autoimmune myasthenia gravis.
    Li H; Shi FD; Bai X; Huang Y; Diab A; He B; Link H
    J Neurol Sci; 1998 Nov; 161(1):40-6. PubMed ID: 9879680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
    Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG; Zhang GX; Xiao BG; Link H
    Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis.
    Zhang GX; Yu LY; Shi FD; Xiao BG; Björk J; Hedlund G; Link H
    J Neuroimmunol; 1997 Mar; 73(1-2):175-82. PubMed ID: 9058774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats.
    Shi FD; Zhang GX; Bai XF; Van der Meide PH; Link H
    Clin Exp Immunol; 1997 Jun; 108(3):523-8. PubMed ID: 9182902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD; Bai XF; Li HL; Huang YM; Van der Meide PH; Link H
    Clin Exp Immunol; 1998 Mar; 111(3):506-12. PubMed ID: 9528890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
    Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.
    Feferman T; Maiti PK; Berrih-Aknin S; Bismuth J; Bidault J; Fuchs S; Souroujon MC
    J Immunol; 2005 May; 174(9):5324-31. PubMed ID: 15843529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats.
    Zhang GX; Ma CG; Xiao BG; van de Meide PH; Link H
    Eur J Immunol; 1996 Nov; 26(11):2552-8. PubMed ID: 8921938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental autoimmune myasthenia gravis after CD8 depletion is associated with decreased IFN-gamma and IL-4.
    Zhang GX; Ma CG; Xiao BG; Bakhiet M; Ljungdahl A; Olsson T; Link H
    Scand J Immunol; 1995 Oct; 42(4):457-65. PubMed ID: 7569779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.
    Bakhiet M; Yu LY; Ozenci V; Khan A; Shi FD
    Clin Exp Immunol; 2006 May; 144(2):290-8. PubMed ID: 16634803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis.
    Maurer M; Bougoin S; Feferman T; Frenkian M; Bismuth J; Mouly V; Clairac G; Tzartos S; Fadel E; Eymard B; Fuchs S; Souroujon MC; Berrih-Aknin S
    Acta Neuropathol Commun; 2015 Jan; 3():1. PubMed ID: 25627031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and the pathogenesis of myasthenia gravis.
    Zhang GX; Navikas V; Link H
    Muscle Nerve; 1997 May; 20(5):543-51. PubMed ID: 9140360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine and chemokine expression kinetics after corneal transplantation.
    King WJ; Comer RM; Hudde T; Larkin DF; George AJ
    Transplantation; 2000 Oct; 70(8):1225-33. PubMed ID: 11063345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.